1 Phase I Study of Safety and Pharmacokinetics of GDC-0917, an Antagonist of Inhibitor of Apoptosis Proteins in Patients with Refractory Solid Tumors or Lymphoma

First Page		Document Content
Date: 2014-05-12 19:51:02		1 Phase I Study of Safety and Pharmacokinetics of GDC-0917, an Antagonist of Inhibitor of Apoptosis Proteins in Patients with Refractory Solid Tumors or Lymphoma Add to Reading List Source URL: www.curis.com Download Document from Source Website File Size: 641,52 KB Share Document on Facebook